Sagimet Biosciences Inc (SGMT)
4.06
+0.14
(+3.57%)
USD |
NASDAQ |
Apr 26, 16:00
4.07
+0.01
(+0.25%)
After-Hours: 20:00
Sagimet Biosciences Shareholders Equity (Quarterly): 91.06M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 91.06M |
September 30, 2023 | 97.88M |
June 30, 2023 | -198.41M |
Date | Value |
---|---|
March 31, 2023 | -192.70M |
December 31, 2022 | -186.95M |
March 31, 2021 | -140.58M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-198.41M
Minimum
Jun 2023
97.88M
Maximum
Sep 2023
-88.28M
Average
-163.77M
Median
Shareholders Equity (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 405.33M |
89bio Inc | 536.31M |
Viking Therapeutics Inc | 933.89M |
Akero Therapeutics Inc | 535.31M |
Arrowhead Pharmaceuticals Inc | 160.41M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 96.72M |
Total Liabilities (Quarterly) | 5.654M |